These findings suggest that FGFR3::TACC3 fusion is not a part of the molecular portrait of PLNTY and that PLNTYs reported to have FGFR3::TACC3 fusion were likely misdiagnosed, because none of these cases was analyzed for DNA methylation profile to confirm a match to this tumor methylation class [30,31,37,42]. The gene discussed is FGFR3; the disease is neoplasm.